ArticleCancer communications (London, England)2025

CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

Jiaqi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.